Patterns of symptom improvement during antidepressant treatment of delusional depression

Psychiatry Research

Volumn 94, Issue 2, 2000, Pages 185-190

  Serretti, Alessandro ^a   Lattuada, Enrico ^a   Zanardi, Raffaella ^a   Franchini, Linda ^a   Smeraldi, Enrico ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Anxiety; Cognition; Depression; Insomnia; Treatment outcome

Indexed keywords

ANTIDEPRESSANT AGENT; FLUVOXAMINE;

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELUSION; DEPRESSION; FEMALE; HAMILTON SCALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BIPOLAR DISORDER; DELUSIONS; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUVOXAMINE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 0034656961     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(00)00139-6     Document Type: Article

References (40)

1. Practice guideline for major depressive disorder in adults. American Journal of Psychiatry. 150:1993;1-26.
2. American Psychiatric Association, 1994a. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association, Washington, DC.
3. Practice guideline for the treatment of patients with bipolar disorder. American Journal of Psychiatry. 151:1994;1-36.
4. Amin M.M. Treatment of insomnia in old age. Psychopharmacology Bulletin. 12:1976;52-55.
5. Bech P., Malt U., Dencker S., Ahlfors U., Elgen K., Lewander T., Lundell A., Simpson G., Lingjaerde O. Scales for assessment of diagnosis and severity of mental disorders. Acta Psychiatrica Scandinavica. 372(Suppl. 87):1993;37-40.
6. Bellini L., Gatti F., Gasperini M., Smeraldi E. A comparison between delusional and non-delusional depressives. Journal of Affective Disorders. 25:1992;129-138.
7. Brim J., Wetzel R.D., Reich T., Wood D., Viesselman J., Rutt C. Primary and secondary affective disorder: Part III. Longitudinal differences in depression symptoms. Journal of Clinical Psychiatry. 45:1984;64-69.
8. Coryell W., Leon A., Winokur G., Endicott J., Keller M., Akiskal H.S., Solomon D. Importance of psychotic features to long-term course in major depressive disorder. American Journal of Psychiatry. 153:1996;483-489.
9. Coryell W. Psychotic depression. Journal of Clinical Psychiatry. 57(Suppl. 3):1996;27-31.
10. Elkin I., Gibbons R.D., Shea M.T., Sotsky S.M., Watkins J.T., Pilkonis P.A., Hedeker D. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Journal of Consulting and Clinical Psychology. 63:1995;841-847.
11. Gasperini M., Gatti F., Bellini L., Anniverno R., Smeraldi E. Perspectives in clinical psychopharmacology of amitriptyline and fluvoxamine. A double-blind study in depressed inpatients. Neuropsychobiology. 26:1992;186-192.
12. Gatti F., Bellini L., Gasperini M., Perez J., Zanardi R., Smeraldi E. Fluvoxamine alone in the treatment of delusional depression. American Journal of Psychiatry. 153:1996;414-416.
13. Gibbons R.D., Hedeker D., Elkin I., Waternaux C., Kraemer H.C., Greenhouse J.B., Shea M.T., Imber S.D., Sotsky S.M., Watkins J.T. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH Treatment of Depression Collaborative Research Program dataset. Archives of General Psychiatry. 50:1993;739-750.
14. Goodwin F., Jamison K. Manic-Depressive Illness. 1990;Oxford University Press, New York.
15. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology. 6:1967;278-296.
16. Hedeker D., Gibbons R.D. MIXREG: a computer program for mixed-effects regression analysis with autocorrelated errors. Computer Methods and Programs in Biomedicine. 49:1996;229-252.
17. Horden A., Holt N.F., Burt C.G., Gordon W.F. Amitriptyline in depressive states. British Journal of Psychiatry. 109:1963;815-825.
18. Johnson J., Horwath E., Weissman M.M. The validity of major depression with psychotic features based on a community study. Archives of General Psychiatry. 48:1991;1075-1081.
19. Jouvent R., Lehouezec J., Payan C., Mikkelsen H., Fermanian J., Millet V., Dufour H. Dimensional assessment of onset of action of antidepressants - a comparative study of moclobemide vs clomipramine in depressed patients with blunted affect and psychomotor retardation. Psychiatry Research. 79:1998;267-275.
20. Kantor S.J., Glassman A.H. Delusional depression: natural history and response to treatment. British Journal of Psychiatry. 133:1977;351-360.
21. Katz M.M., Koslow S.H., Maas J.W., Frazer A., Kocsis J., Secunda S., Bowden C.L., Casper R.C. Identifying the specific clinical actions of amitriptyline: interrelationships of behavior, affect and plasma levels in depression. Psychological Medicine. 21:1991;599-611.
22. Kendler K.S., Glazer W.M., Morgenstern H. Dimensions of delusional experience. American Journal of Psychiatry. 140:1983;466-469.
23. Lattuada E., Serretti A., Cusin C., Gasperini M., Macciardi F., Smeraldi E. Symptomatologic analysis of psychotic and non-psychotic depression. Journal of Affective Disorders. 54:1999;183-187.
24. Leckman J.F., Sholomskas D., Thompson W.D., Belanger A., Weissman M.M. Best estimate of lifetime psychiatric diagnosis: a methodological study. Archives of General Psychiatry. 39:1982;879-883.
25. Meyers B.S., Greenberg R. Late-life delusional depression. Journal of Affective Disorders. 11:1986;133-137.
26. Nelson J.C., Bowers M.B. Delusional unipolar depression: description and drug response. Archives of General Psychiatry. 35:1978;1321-1328.
27. Parker G., Roy K., Hadzi-Pavlovic D., Pedic F. Psychotic (delusional) depression: a meta-analysis of physical treatments. Journal of Affective Disorders. 24:1992;17-24.
28. Pies R.W. Must we now consider SRIs neuroleptics? Journal of Clinical Psychopharmacology. 17:1997;443-445.
29. Roose S., Glassman A. Delusional depression. Georgotas A., Cancro R. Depression and Mania. 1988;76-85 Elsevier Science Publishing Co., Inc, New York.
30. Serretti A., Lattuada E., Cusin C., Macciardi F., Smeraldi E. Analysis of depressive symptomatology in mood disorders. Depression and Anxiety. 8:1998;80-85.
31. Serretti A., Jori M.C., Casadei G., Ravizza L., Smeraldi E., Akiskal H. Delineating psychopathologic clusters within dysthymia: a study of 512 patients. Journal of Affective Disorders. 56:1999;17-25.
32. Sobin C.A., Sackeim H. Psychomotor symptoms of depression. American Journal of Psychiatry. 154:1997;4-17.
33. Spiker D.G., Kupfer D.J. Placebo response rates in psychotic and nonpsychotic depression. Journal of Affective Disorders. 14:1988;21-23.
34. Takahashi R., Sakuma A., Hara T., Kazamatsuri H., Mori A., Saito Y., Murasaki M., Oguchi T., Sakurai Y., Yuzuriha T., Takemura M., Kurokawa H., Kurita H. Comparison of efficacy of amoxapine and imipramine in a multi-clinic double-blind study using the WHO schedule for a standard assessment of patients with depressive disorders. Journal of International Medical Research. 7:1979;7-18.
35. Vaisanen E., Naarala M., Kontiainen H., Merilainen V., Heikkila L., Malinen L. Maprotiline and doxepin in the treatment of depression. A double-blind multicenter comparison. Acta Psychiatrica Scandinavica. 57:1978;193-201.
36. Worthington J., Fava M., Davidson K., Alpert J., Nierenberg A.A., Rosenbaum J.F. Patterns of improvement in depressive symptoms with fluoxetine treatment. Psychopharmacology Bulletin. 31:1995;223-226.
37. Young J.P., Hughes W.C., Lader M.H. A controlled comparison of flupenthixol and amitriptyline in depressed outpatients. British Medical Journal. 1:1976;1116-1118.
38. Zanardi R., Franchini L., Gasperini M., Perez J., Smeraldi E. Double-blind controlled trial of sertraline vs. paroxetine in the treatment of delusional depression. American Journal of Psychiatry. 153:1996;1631-1633.
39. Zanardi R., Franchini L., Gasperini M., Smeraldi E., Perez J. Long-term treatment of psychotic (delusional) depression with fluvoxamine: an open pilot study. International Clinical Psychopharmacology. 12:1997;195-197.
40. Zanardi R., Franchini L., Gasperini M., Lucca L., Smeraldi E., Perez J. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study. Journal of Clinical Psychopharmacology. 18:1998;441-446.